Comparison of the efficacy between diclofenac phonophoresis and ultrasound therapy in myofascial pain syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210319004

Enrollment

Registered

2021-03-19

Start date

2020-11-19

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

participant conditions : healthy participant 18-75 year old with myofascial pain syndrome at trapezius muscle participant conditions : healthy participant 18-75 year old with myofascial pain syndrome at trapezius muscle

Interventions

use diclofenac phonophoresis in treatment myofascial pain syndrome in trapezius muscle with continuous mode 1 watt/cm2 1 Mhz in 10 minutes (in the same mode with arm2),use standard ultrasound in trea

Experimental Drug,Active Comparator Device

diclofenac phonophoresis,standard ultrasound

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: participants (18-75 years old) with myofascial pain at trapezius muscle

Exclusion criteria

Exclusion criteria: history surgery or trauma at neck area fribomyalgia cervical herniation cervical radiculopathy cervical myelopathy Nsaids or ultrasound gel allergy pregnancy , lactation recent recieved physiotherapy in 3 month ago

Design outcomes

Primary

Measure	Time frame
pain 0-10 scale visual analog scale	—

Secondary

Measure	Time frame
range of motion 0-45 degree standard goniometry	—

Countries

Thailand

Contacts

Public Contactthreenuch amornpinyokiat

taksin hospital

threenuchie@gmail.com0825446699

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026